Skip to main content
Major risk

Ibogaine and Terbinafine

Also known as: Lamisil

Potent CYP2D6 inhibitor. Oral form has long half-life.

Severity

Major risk

Mechanism

CYP2D6 inhibition

Protocol Status

Pre-arrival washout (under your prescribing physician)

Restart Delay

Physician discretion

What "Major risk" Means

Serious clinical risk requiring physician-led tapering, washout, and monitoring. Treatment may proceed once the medication is appropriately cleared or transitioned.

Clinical Action

What our medical team does for patients on Terbinafine.

Discontinue oral terbinafine minimum 14 days before treatment. Topical is fine.

Where the Washout Happens

Pre-arrival washout (under your prescribing physician)

Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose.

Pre-Treatment Washout Window

14 days minimum before treatment.

Post-Treatment Restart

Restart at physician discretion once acute window closes.

The Pharmacology

How Terbinafine interacts with ibogaine: cyp2d6 inhibition.

Ibogaine is metabolised primarily by hepatic CYP2D6 into noribogaine. Drugs that inhibit CYP2D6 slow this conversion, so plasma ibogaine rises to higher peaks and stays there longer. Higher peaks deepen the experience and amplify QTc prolongation. CYP2D6-inhibiting medications are tapered and discontinued well before treatment to ensure predictable pharmacokinetics.

Same Mechanism

Other medications that interact via cyp2d6 inhibition.

Major risk

Bupropion

Wellbutrin, Zyban

Same Severity Tier

Other major risk medications (different mechanism).

Opioid receptor potentiation

Methadone

Methadose, Dolophine

Opioid receptor potentiation

Buprenorphine

Suboxone, Subutex

Opioid receptor potentiation

Fentanyl

Duragesic, Sublimaze

Opioid receptor potentiation

Oxycodone

Oxycontin, Percocet

Opioid receptor potentiation

Hydrocodone

Vicodin, Norco

Opioid receptor potentiation

Morphine

Ms Contin, Kadian

Common Questions

Terbinafine and ibogaine treatment.

Can I take ibogaine if I am on Terbinafine?

Major risk. Potent CYP2D6 inhibitor. Oral form has long half-life. Discontinue oral terbinafine minimum 14 days before treatment. Topical is fine.

How long do I need to be off Terbinafine before ibogaine treatment?

Pre-arrival washout (under your prescribing physician). Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose. 14 days minimum before treatment.

What is the mechanism of the interaction?

CYP2D6 inhibition. Ibogaine is metabolised primarily by hepatic CYP2D6 into noribogaine. Drugs that inhibit CYP2D6 slow this conversion, so plasma ibogaine rises to higher peaks and stays there longer. Higher peaks deepen the experience and amplify QTc prolongation. CYP2D6-inhibiting medications are tapered and discontinued well before treatment to ensure predictable pharmacokinetics.

Can I switch to a different medication so I can have ibogaine treatment?

In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Terbinafine — contact us for an individual review.

Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.

Browse all 103 medications in the A–Z directory.

DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: May 2026 · See full medical team
Need a Personal Review

On Terbinafine? Talk to our medical team.

Every patient on a flagged medication gets an individual washout plan from our admissions physician — typically within 24 hours and free of charge.

Book Free Consultation

100% Confidential · No Obligation